Wall Street's top pot analyst loves Cronos deal for Altria: 'Unique entry into cannabis'
December 10, 2018 at 08:14 AM EST
Wall Street's top marijuana analyst likes Marlboro maker Altria's $1.8 billion investment in Canadian pot company Cronos Group, telling clients the move represents a "unique entry into cannabis."